Our next course “An update in Pharmacoeconomics in the Irish Healthcare Setting” will take place on 23rd and 24th March 2015. A programme will be available shortly. NCPE Course Booking Form 2015
The NCPE finds dimethyl fumarate (Tecfidera®) not cost-effective for the treatment of adult patients with relapsing remitting MS and therefore does not recommend reimbursement at the submitted price
The NCPE Review Group concludes that, at the current price, pregabalin (Lyrica®) is not cost effective as a first line treatment for generalised anxiety disorder.